相似文献
1
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.头孢噻肟与拉氧头孢的药代动力学及组织浓度比较。
Antimicrob Agents Chemother. 1980 Sep;18(3):369-71. doi: 10.1128/AAC.18.3.369.
2
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.头孢噻肟、拉氧头孢和头孢他啶的多剂量比较药代动力学
Antimicrob Agents Chemother. 1981 Nov;20(5):567-75. doi: 10.1128/AAC.20.5.567.
3
Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.正常志愿者中拉氧头孢、头孢哌酮和头孢噻肟的比较药代动力学
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S585-94. doi: 10.1093/clinids/4.supplement_3.s585.
4
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.头孢哌酮、头孢噻肟和拉氧头孢的比较药代动力学
Antimicrob Agents Chemother. 1983 Mar;23(3):429-34. doi: 10.1128/AAC.23.3.429.
5
A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.头孢曲松、拉氧头孢和头孢噻肟的药代动力学及组织穿透性比较。
Eur J Clin Microbiol. 1983 Oct;2(5):505-8. doi: 10.1007/BF02013917.
6
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.羟羧氧酰胺菌素、头孢噻肟、头孢哌酮和头孢曲松在实验性细菌性脑膜炎中的药代动力学及细菌学疗效
J Infect Dis. 1981 Feb;143(2):156-63. doi: 10.1093/infdis/143.2.156.
7
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.头孢噻肟、拉氧头孢和头孢他啶的比较多剂量药代动力学。
Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S581-4. doi: 10.1093/clinids/4.supplement_3.s581.
8
Clinical pharmacology of moxalactam in patients with malignant disease.莫西拉坦在恶性疾病患者中的临床药理学。
Antimicrob Agents Chemother. 1981 Apr;19(4):639-44. doi: 10.1128/AAC.19.4.639.
9
Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.正常志愿者中莫西拉坦与头孢唑林的药代动力学比较。
Antimicrob Agents Chemother. 1981 Feb;19(2):302-5. doi: 10.1128/AAC.19.2.302.
10
Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.正常受试者中莫拉卡坦的单剂量和多剂量药代动力学。
Antimicrob Agents Chemother. 1982 Jul;22(1):94-102. doi: 10.1128/AAC.22.1.94.
引用本文的文献
1
Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function.肾功能受损患者头孢噻肟的生理药代动力学模型
Clin Pharmacokinet. 2025 Feb;64(2):257-273. doi: 10.1007/s40262-024-01469-x. Epub 2025 Jan 7.
2
Third generation cephalosporins in the parenteral to oral switch.肠外给药转换为口服给药的第三代头孢菌素
Pharmacoeconomics. 1994;5(Suppl 2):27-33. doi: 10.2165/00019053-199400052-00006.
3
Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.阿莫西林和头孢噻肟在生理浓度下对肺炎链球菌的活性：体外药效学模拟
Antimicrob Agents Chemother. 1996 Dec;40(12):2904-6. doi: 10.1128/AAC.40.12.2904.
4
Comparative pharmacokinetics of ceftazidime and moxalactam.头孢他啶和拉氧头孢的比较药代动力学
Antimicrob Agents Chemother. 1982 Aug;22(2):237-41. doi: 10.1128/AAC.22.2.237.
5
Peritoneal absorption of moxalactam.莫西拉坦的腹膜吸收
Antimicrob Agents Chemother. 1983 Jul;24(1):39-41. doi: 10.1128/AAC.24.1.39.
6
The pharmacokinetics of new cephalosporins: significance in clinical practice.新型头孢菌素的药代动力学：在临床实践中的意义。
Bull N Y Acad Med. 1984 May;60(4):327-39.
7
Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.同时静脉输注后头孢唑林和拉氧头孢的药代动力学
Antimicrob Agents Chemother. 1981 Nov;20(5):576-9. doi: 10.1128/AAC.20.5.576.
8
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.头孢哌酮：对其体外抗菌活性、药理特性及治疗效果的综述。
Drugs. 1981 Dec;22(6):423-60. doi: 10.2165/00003495-198122060-00002.
9
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.正常肾功能和肾功能受损受试者中莫拉卡坦的药代动力学。
Antimicrob Agents Chemother. 1981 Jun;19(6):965-71. doi: 10.1128/AAC.19.6.965.
10
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
本文引用的文献
1
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.蛋白质结合对六种β-内酰胺类抗生素组织液水平的影响。
J Infect Dis. 1980 Jul;142(1):77-82. doi: 10.1093/infdis/142.1.77.
2
Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins.头孢噻肟（HR756）去乙酰代谢物与头孢噻肟及其他头孢菌素的活性比较。
Antimicrob Agents Chemother. 1980 Jan;17(1):84-6. doi: 10.1128/AAC.17.1.84.
3
[Cefazolin, a new broad-spectrum antibiotic (author's transl)].头孢唑林，一种新型广谱抗生素（作者译）
Dtsch Med Wochenschr. 1973 Dec 21;98(51):2448-50. doi: 10.1055/s-0028-1107275.
4
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.LY127935，一种新型氧杂β-内酰胺：与其他β-内酰胺抗生素的体外比较
Antimicrob Agents Chemother. 1979 Sep;16(3):341-5. doi: 10.1128/AAC.16.3.341.
5
In vitro activity of LY127935.LY127935的体外活性。
Antimicrob Agents Chemother. 1979 Sep;16(3):287-92. doi: 10.1128/AAC.16.3.287.
6
HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.HR 756，一种高效头孢菌素：与头孢唑林和羧苄青霉素的比较。
Antimicrob Agents Chemother. 1978 Dec;14(6):807-11. doi: 10.1128/AAC.14.6.807.
Zotero 插件